APA (7th ed.) Citation

W, E., S, S., A, K., N, K., CM, D., C, B., . . . S, D. (2017). NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis. Clinical chemistry and laboratory medicine, 56(1), 147. https://doi.org/10.1515/cclm-2017-0156

Chicago Style (17th ed.) Citation

W, Eilenberg, et al. "NGAL and MMP-9/NGAL as Biomarkers of Plaque Vulnerability and Targets of Statins in Patients with Carotid Atherosclerosis." Clinical Chemistry and Laboratory Medicine 56, no. 1 (2017): 147. https://doi.org/10.1515/cclm-2017-0156.

MLA (9th ed.) Citation

W, Eilenberg, et al. "NGAL and MMP-9/NGAL as Biomarkers of Plaque Vulnerability and Targets of Statins in Patients with Carotid Atherosclerosis." Clinical Chemistry and Laboratory Medicine, vol. 56, no. 1, 2017, p. 147, https://doi.org/10.1515/cclm-2017-0156.